Skip to main content
Full access
Letters
Published Online: 1 April 2013

Reversible Parietal Hypometabolism in Late-Onset Psychosis

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Late-onset psychosis constitutes a major diagnostic challenge, especially the differentiation between a late presentation of a psychotic disorder versus a behavioral presentation of Alzheimer’s disease (AD). Among others, reduced parietal and posterior temporal glucose metabolism is used as a supportive feature for the diagnosis of AD.1 We report a case with late-onset psychosis, cognitive impairment including memory, and reduced glucose metabolism on 18F-FDG PET including parietal cortex, suggestive of AD. However, during follow-up, cognitive status improved; parietal metabolism increased; and an 11C-PIB-PET scan was negative, warranting cautious interpretation of metabolic changes in late-onset psychosis.

Case Report

A 74-year-old woman with a history of depression, craniocerebral trauma during adulthood, and a TIA, was admitted to the neurosurgery department because of pain in the right lower limb due to lumbosacral plexopathy. While undergoing examinations, she became convinced that her hospital stay was part of a conspiracy, that she was being used for medical experiments, and was to be poisoned by medication. She accused one physician of maltreating her, sent secret messages by phone, accused caregivers of theft, and believed that walls were permeable through invisible holes. A disturbance of consciousness was never observed. Subjective memory complaints were present before admission, and cognitive difficulties were observed during hospitalization, confirmed by MMSE (15/30). An antipsychotic drug was started, and she was referred to the geriatric psychiatry ward. Mental examination at admission revealed a conscious, cooperative, but suspicious woman with paranoid delusions without hallucinations, incoherent formal thinking, and disorganized speech. Neuropsychological testing revealed poor sustained attention, executive dysfunction, and episodic memory impairment. MRI showed periventricular leukomalacia, but no recent ischemia. 18F-FDG PET revealed severe hypometabolism of bilateral parietal, posterior temporal and frontal cortex (Figure 1), a pattern suggestive of AD. Psychotic symptoms improved gradually, as well as cognitive status, with an MMSE score of 25 after 15 weeks of hospitalization. A follow-up 18F-FDG PET, 3 months after the initial one, showed a relative increase of parietal metabolism. During 4 years of follow-up, cognitive status remained stable despite memory complaints. An 11C-PIB PET did not show abnormal cortical amyloid deposition (Figure 1). However delusional ideas persisted, allowing a diagnosis of very-late-onset schizophrenia-like psychosis.2
FIGURE 1. Neuroimaging in Late-Onset Psychosis, as Compared With Alzheimer’s Disease
[A–E]: Neuroimaging results from a 74-year-old woman with late-onset psychosis. [A]: Upper row 18F-FDG PET scan. Lower row: stereotactic surface projections with areas of significant hypometabolism superimposed (z-scores with respect to normal dataset of 30 control subjects); [B]: Follow-up 18F-FDG PET scan after 3 months; [C]: Subtraction of [A] from [B]. Yellow indicates significant increase, and blue significant decrease of metabolism; [D]: MRI scan including axial slices of a FLAIR sequence and a coronal slice at the level of the hippocampus of a T2-weighted sequence; [E]: Negative 11C-PIB PET scan (standard uptake value ratio [SUVR] values are used as a measure of amyloid binding); [F–G]: neuroimaging results from 71-year-old woman with Alzheimer’s disease; [F]: 18F-FDG PET data; and [G]: a positive 11C-PIB PET scan.

Discussion

Late-onset delusions may be an early symptom of AD. On the other hand, psychotic disorders in elderly persons are often associated with cognitive impairment. Because of the clinical overlap, neuroimaging is considered an important diagnostic tool, with temporoparietal hypometabolism and a positive 11C-PIB PET being supportive of AD diagnosis.1 In contrast, neuroimaging findings in late-onset psychotic disorders that have been described so far, are generally nonspecific, including enlarged ventricles, white-matter changes,3 and hypoperfusion of frontal and temporal cortex measured by SPECT.4,5 Until now, no 18F-FDG PET studies have been reported in late-onset psychosis. Our case report illustrates that, in addition to frontal metabolic changes, late-onset psychosis can be associated with severe parietal hypometabolism. In contrast with the natural evolution of AD, we observed a partial recuperation of parietal hypometabolism over time associated with improvement of cognitive status and reduction of psychotic symptoms.

References

1.
Dubois B, Feldman HH, Jacova C, et al.: Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6:734–746
2.
Howard R, Rabins PV, Seeman MV, et al.: The International Late-Onset Schizophrenia Group: Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatry 2000; 157:172–178
3.
Howard R: Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis, in the Oxford Textbook of Old Age Psychiatry. Edited by, Jacoby R, Oppenheimer C, Dening T, et al. New York, Oxford University Press Inc., 2008, pp 617–626
4.
Miller BL, Lesser IM, Mena I, et al.: Regional cerebral blood flow in late-life onset psychosis. Neuropsychiatry Neuropsychol Behav Neurol 1992; 158:132–137
5.
Sachdev P, Brodaty H, Rose N, et al.: Regional cerebral blood flow in late-onset schizophrenia: a SPECT study using 99mTc-HMPAO. Schizophr Res 1997; 27:105–117

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E32 - E33
PubMed: 23686054

History

Published online: 1 April 2013
Published in print: Spring 2013

Authors

Affiliations

I. Van Poeck, M.D.
University of Leuven, Herestraat 49, 3000 Leuven, Belgium
R. Ahmad, M.D.
University of Leuven, Herestraat 49, 3000 Leuven, Belgium
K. Van Laere, M.D., Ph.D.
University of Leuven, Herestraat 49, 3000 Leuven, Belgium
M. Vandenbulcke, M.D., Ph.D.
University of Leuven, Herestraat 49, 3000 Leuven, Belgium

Notes

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share